Physician profile
Nathan Mohr
NPI 1679066559
$9,361.93
in general payments reported to CMS, 2019-2025
11 companies · $3,686 in 2025
The $3,686 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.37 · 2021: $293 · 2022: $247 · 2023: $636 · 2024: $4,487 · 2025: $3,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,805 · Travel and Lodging: $3,679 · Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,805.00 |
| Travel and Lodging | $3,679.34 |
| Food and Beverage | $1,324.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,084.73 | 2022-2025 | |
| W. L. Gore & Associates, INC. | $370.36 | 2021-2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Medical Device Business Services, INC. | $305.00 | 2023 | |
| Medtronic, INC. | $189.48 | 2022 | |
| Davol INC. | $128.75 | 2025 | Phasix Mesh |
| Boston Scientific Corporation | $117.96 | 2023 | Spyglass |
| Ethicon US, LLC | $99.79 | 2023 | Echelon Endopath, Echelon Flex |
| Conmed Corporation | $20.96 | 2023 | Airseal |
| Merck Sharp & Dohme LLC | $17.16 | 2025 | Bridion |
| Becton, Dickinson and Company | $15.37 | 2023 | Phasix Mesh |
| Covidien LP | $12.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Mohr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.